Company: SXTPW
Filing Date: 2025-02-06
Form Type: 424B5
Source: 0001213900-25-010772
Chunk: 96

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 424B5
Chunk 96
---
 as depositary for that global security and we do not appoint another 
 institution to act as depositary within 90 days;                                                                                        |

| ● | if we notify any applicable                                
 trustee that we wish to terminate that global security; or |

| ● | if an event of default                                                                                       
 has occurred with regard to securities represented by that global security and has not been cured or waived. |

The applicable prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities covered by the applicable prospectus supplement. When a global security terminates, the depositary, and not we or any applicable trustee, is responsible for deciding the names of the institutions that will be the initial direct holders.

<div align='center'>33

PLAN OF DISTRIBUTION</div>

We may sell the securities from time to time pursuant to underwritten public offerings, direct sales to the public, negotiated transactions, block trades or a combination of these methods. We may sell the securities to or through underwriters or dealers, through agents, or directly to one or more purchasers. We may distribute securities from time to time in one or more transactions:

| ● | at a fixed price or prices, 
 which may be changed;       |

| ● | at market prices prevailing 
 at the time of sale;        |

| ● | at prices related to such    
 prevailing market prices; or |

| ● | at negotiated prices. |

A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the securities, including, to the extent applicable:

| ● | the name or names of the 
 underwriters, if any;    |

| ● | the purchase price of the                                                                            
 securities or other consideration therefor, and the proceeds, if any, we will receive from the sale; |

| ● | any options under which                                  
 underwriters may purchase additional securities from us; |

| ● | any agency fees or underwriting                                               
 discounts and other items constituting agents’ or underwriters’ compensation; |

| ● | any public offering price; |

| ● | any discounts or concessions                 
 allowed or reallowed or paid to dealers; and |

| ● | any securities exchange                          
 or market on which the securities may be listed. |

Only underwriters named in the prospectus supplement will be underwriters of the securities offered by the prospectus supplement.

If underwriters are used in the sale, they will acquire the securities for their own